Cortex – Life Sciences Insights

9/11/2024 2:05:35 PM

Navigating EU and national regulatory scrutiny in so called “killer acquisitions”

By Alexandra Kamerling Darach Connolly Zoltan Marosi +2 more...

The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...

9/18/2023 8:51:49 AM

By Nicholas Tyacke Robynne Sanders Greg Bodulovic +2 more...

The quintessential right of a patentee is to exclusively exploit their invention (and authorise others to do so) during the term of the...

4/17/2023 3:43:23 PM

By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart +2 more...

ESG is increasingly a primary focus for companies and consumers alike. Across all industries, companies are under immense scrutiny from...

6/20/2021 11:05:32 PM

By Nicholas Tyacke Ben Mawby Sarah Parkin

Summary In a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...

10/23/2020 12:00:00 AM

By Dr Kokularajah Paheenthararajah

This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...

11/2/2017 4:12:22 PM

By DLA Piper

How far does the new doctrine of equivalents introduced by the UK Supreme Court in Eli Lilly v Actavis really extend the scope of patent...